TY - JOUR
T1 - Antibodies to the estrogen receptor-α modulate rapid prolactin release from rat pituitary tumor cells through plasma membrane estrogen receptors
AU - Norfleet, Andrea M.
AU - Clarke, Charlotte H.
AU - Gametchu, Bahiru
AU - Watson, Cheryl S.
PY - 2000
Y1 - 2000
N2 - Antibodies (Abs) raised against the estrogen receptor-α (ERα) were used to investigate the role of ERα proteins located at the plasma membrane in mediating the rapid, estrogen-stimulated secretion of prolactin (PRL) from rat pituitary GH3/B6/F10 cells. Exposure of the cells to 1 nM 17β-estradiol (E2) significantly increased PRL release after 3 or 6 min. When ERα Abs that bind specifically to ERα but are too large to diffuse into cells were tested for activity at the cell membrane, Ab R4, targeted to an ERα hinge region sequence, increased PRL release in a time- and concentration-dependent fashion. Ab H151, directed against a different hinge region epitope, decreased PRL release and blocked the stimulatory action of E2. Abs raised against the DNA binding domain (H226) or the carboxyl terminus (C542) were not biologically active. When each Ab was examined for recognition of ERα on the cell surface by immunocytochemistry, all except H151 generated immunostaining in aldehyde-fixed cells. In live cells, however, Ab H151 but not Ab R4 blocked the membrane binding of fluorescently tagged E2-BSA. Overall, the data indicate that plasma membrane ERα proteins mediate estrogen-stimulated PRL release from GH3/B6/F10 cells. These results may also convey information about conformationally sensitive areas of the membrane form of ERα involved in rapid, nongenomic responses to estrogens.
AB - Antibodies (Abs) raised against the estrogen receptor-α (ERα) were used to investigate the role of ERα proteins located at the plasma membrane in mediating the rapid, estrogen-stimulated secretion of prolactin (PRL) from rat pituitary GH3/B6/F10 cells. Exposure of the cells to 1 nM 17β-estradiol (E2) significantly increased PRL release after 3 or 6 min. When ERα Abs that bind specifically to ERα but are too large to diffuse into cells were tested for activity at the cell membrane, Ab R4, targeted to an ERα hinge region sequence, increased PRL release in a time- and concentration-dependent fashion. Ab H151, directed against a different hinge region epitope, decreased PRL release and blocked the stimulatory action of E2. Abs raised against the DNA binding domain (H226) or the carboxyl terminus (C542) were not biologically active. When each Ab was examined for recognition of ERα on the cell surface by immunocytochemistry, all except H151 generated immunostaining in aldehyde-fixed cells. In live cells, however, Ab H151 but not Ab R4 blocked the membrane binding of fluorescently tagged E2-BSA. Overall, the data indicate that plasma membrane ERα proteins mediate estrogen-stimulated PRL release from GH3/B6/F10 cells. These results may also convey information about conformationally sensitive areas of the membrane form of ERα involved in rapid, nongenomic responses to estrogens.
KW - Immunocytochemistry
KW - Membrane steroid receptors
KW - Nongenomic effects
UR - http://www.scopus.com/inward/record.url?scp=0033985036&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0033985036&partnerID=8YFLogxK
U2 - 10.1096/fasebj.14.1.157
DO - 10.1096/fasebj.14.1.157
M3 - Article
C2 - 10627290
AN - SCOPUS:0033985036
SN - 0892-6638
VL - 14
SP - 157
EP - 165
JO - FASEB Journal
JF - FASEB Journal
IS - 1
ER -